Evidence map›Paper›PMID 18490767›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation.

Takashi Sato, Takeshi Shimosato, W Gregory Alvord, Dennis M Klinman

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Tobacco Smoke Exposure Exacerbated Crystalline Silica-Induced Lung Toxicity in Rats.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  5. Article
  6. Article
  7. Silicosis and lung cancer: current perspectives.Lung Cancer (Auckland, N.Z.) · 2018
    Review
  8. Article
  9. Use of nanoparticles to deliver immunomodulatory oligonucleotides.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2016
    Review
  10. Review
  11. Cell-Based Therapy for Silicosis.Stem cells international · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Takashi SatoLaboratory of Experimental Immunology, National Cancer Institute, Frederick, MD 21702, USA.
Takeshi Shimosato
W Gregory Alvord
Dennis M Klinman
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · US

Funding

Mechanism of action and therapeutic utility of immunosuppressive oligonucleotideZIABC010853 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2009 to 2019
$3.8M
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleoZ01BC010852 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLINMAN, DENNIS · 2007 to 2008
$1.9M
Intramural NIH HHS Z01 BC010852
6 · The paper itself

Abstract

Inhalation of silica-containing dust particles induces silicosis, an inflammatory disease of the lungs characterized by the infiltration of macrophages and neutrophils into the lungs and the production of proinflammatory cytokines, chemokines, and reactive oxygen species (ROS). Synthetic oligodeoxynucleotides (ODN) expressing "immunosuppressive motifs" were recently shown to block pathologic inflammatory reactions in murine models of autoimmune disease. Based on those findings, the potential of suppressive ODN to prevent acute murine silicosis was examined. In vitro studies indicate that suppressive ODN blunt silica-induced macrophage toxicity. This effect was associated with a reduction in ROS production and p47phox expression (a subunit of NADPH oxidase key to ROS generation). In vivo studies show that pretreatment with suppressive (but not control) ODN reduces silica-dependent pulmonary inflammation, as manifest by fewer infiltrating cells, less cytokine/chemokine production, and lower levels of ROS (p < 0.01 for all parameters). Treatment with suppressive ODN also reduced disease severity and improved the survival (p < 0.05) of mice exposed to silica.

Indexed as

AnimalsCell LineCytokinesFemaleLungMacrophages, AlveolarMiceMice, Inbred BALB CNADPH OxidasesNeutrophilsOligonucleotidesReactive Oxygen SpeciesSilicon DioxideSilicosisCytokinesNADPH Oxidasesneutrophil cytosolic factor 1OligonucleotidesReactive Oxygen SpeciesSilicon Dioxide

Identifiers

PMID18490767
PMCPMC6335649
OpenAlexW1542158894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.